Frontlight ResearchEarly access
Diabetic eye disease trials in Portugal
1 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in PortugalA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Where
- Almada, Coimbra, Lisbon
- Age
- 18 years and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705555 · EU 2026-526790-42-01